NYSE:MCK - McKesson Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $185.62
  • Forecasted Upside: 3.12 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 10 Buy Ratings
  • 1 Strong Buy Ratings
$180.00
▲ +0.5 (0.28%)
1 month | 3 months | 12 months
Get New McKesson Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MCK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MCK

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$185.62
▲ +3.12% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is $185.62, with a high forecast of $222.00 and a low forecast of $165.00. The average price target represents a 3.12% upside from the last price of $180.00.
Buy
The current consensus among 13 investment analysts is to buy stock in McKesson. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/2/2020
  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/31/2020
  • 1 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/29/2020
  • 1 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/28/2020
  • 1 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/27/2020

Latest Recommendations

  • 1 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2020The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
i
11/13/2020MizuhoBoost Price TargetNeutral$150.00 ➝ $178.00Medium
i
11/5/2020Credit Suisse GroupBoost Price TargetNeutral$174.00 ➝ $178.00Medium
i
11/4/2020Morgan StanleyBoost Price TargetOverweight$204.00 ➝ $219.00High
i
11/4/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$202.00 ➝ $222.00High
i
11/2/2020BarclaysUpgradeEqual Weight ➝ Overweight$166.00 ➝ $166.00Medium
i
8/4/2020JPMorgan Chase & Co.Boost Price TargetPositive ➝ Overweight$187.00 ➝ $198.00Low
i
8/4/2020Credit Suisse GroupBoost Price TargetNeutral$160.00 ➝ $162.00Low
i
Rating by Jailendra Singh at Credit Suisse Group AG
8/4/2020Morgan StanleyBoost Price TargetOverweight$194.00 ➝ $204.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
8/4/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$169.00 ➝ $202.00Medium
i
7/8/2020GuggenheimBoost Price TargetBuy$168.00 ➝ $175.00Medium
i
Rating by Glen Santangelo at Guggenheim
6/15/2020Morgan StanleyBoost Price TargetOverweight$163.00 ➝ $194.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
5/27/2020GuggenheimBoost Price TargetBuy$147.00 ➝ $168.00High
i
Rating by Glen Santangelo at Guggenheim
5/26/2020UBS GroupBoost Price TargetBuy$160.00 ➝ $165.00Low
i
Rating by Kevin Caliendo at UBS Group AG
5/22/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$184.00Low
i
5/22/2020Morgan StanleyBoost Price TargetOverweight$150.00 ➝ $163.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
5/21/2020CowenBoost Price TargetOutperform$174.00 ➝ $186.00Low
i
5/21/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$173.00 ➝ $169.00Low
i
5/21/2020MizuhoBoost Price TargetNeutral$140.00 ➝ $147.00Low
i
5/20/2020CfraLower Price TargetBuy$179.00 ➝ $171.00Medium
i
5/15/2020UBS GroupUpgradeNeutral ➝ Buy$151.00 ➝ $160.00High
i
Rating by Steven Strycula at UBS Group AG
4/22/2020Credit Suisse GroupInitiated CoverageNeutral$146.00Low
i
4/2/2020Credit Suisse GroupLower Price TargetNeutral$155.00 ➝ $147.00High
i
3/31/2020BarclaysLower Price TargetEqual Weight$170.00 ➝ $163.00Medium
i
3/27/2020Morgan StanleyLower Price TargetOverweight$182.00 ➝ $150.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
3/18/2020Credit Suisse GroupReiterated RatingHold$145.00Medium
i
3/18/2020JPMorgan Chase & Co.Boost Price TargetOverweight$186.00 ➝ $187.00High
i
3/18/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$173.00 ➝ $174.00High
i
3/13/2020GuggenheimUpgradeNeutral ➝ BuyMedium
i
3/6/2020Morgan StanleyReiterated RatingBuy$182.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
2/11/2020Morgan StanleyBoost Price TargetOverweight$168.00 ➝ $182.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
2/7/2020Robert W. BairdUpgradeNeutral ➝ Outperform$164.00 ➝ $197.00Medium
i
2/5/2020Robert W. BairdBoost Price TargetNeutral$161.00 ➝ $164.00Medium
i
2/5/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$153.00 ➝ $173.00Medium
i
2/5/2020Morgan StanleyBoost Price TargetOverweight$162.00 ➝ $168.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
1/19/2020BarclaysReiterated RatingHold$170.00Low
i
1/15/2020MizuhoBoost Price TargetNeutral$137.00 ➝ $140.00High
i
1/10/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$135.00 ➝ $162.00Medium
i
1/9/2020UBS GroupDowngradeSell$147.00High
i
Rating by Steven Strycula at UBS Group AG
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$155.00Medium
i
9/5/2019Cleveland ResearchReiterated RatingHoldLow
i
Rating by Rob Eich at Cleveland Research
8/27/2019Morgan StanleyBoost Price TargetEqual Weight$130.00 ➝ $135.00High
i
8/5/2019Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
i
7/31/2019Bank of AmericaSet Price TargetBuy$160.00N/A
i
Rating by Michael Cherny at Bank of America Co.
7/22/2019Credit Suisse GroupInitiated CoverageNeutral$143.00Low
i
7/22/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$152.00Low
i
7/22/2019JPMorgan Chase & Co.Initiated CoverageOverweight$164.00Low
i
4/2/2019Wolfe ResearchInitiated CoverageOutperformHigh
i
2/1/2019BarclaysReiterated RatingHold$130.00Medium
i
1/25/2019Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$175.00Low
i
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$134.00Low
i
1/6/2019BarclaysReiterated RatingHold$124.00Low
i
12/9/2018Morgan StanleyLower Price Target$142.00 ➝ $130.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
12/3/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$142.00 ➝ $130.00Medium
i
10/26/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$150.00 ➝ $136.00High
i
10/26/2018Royal Bank of CanadaSet Price TargetHold$155.00Medium
i
Rating by George Hill at Royal Bank of Canada
8/12/2018MizuhoReiterated RatingHold$133.00High
i
7/27/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$181.00 ➝ $160.00Low
i
7/27/2018Jefferies Financial GroupReiterated RatingBuy$160.00Medium
i
7/27/2018Royal Bank of CanadaReiterated RatingHold$152.00Medium
i
Rating by George Hill at Royal Bank of Canada
7/20/2018Robert W. BairdDowngradeOutperform ➝ NeutralLow
i
7/20/2018CitigroupLower Price TargetBuy$160.00 ➝ $2.86Low
i
7/10/2018Standpoint ResearchUpgradeHold ➝ BuyLow
i
7/3/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $142.00Low
i
6/29/2018Royal Bank of CanadaLower Price TargetMarket Perform$158.00High
i
5/29/2018SVB LeerinkSet Price TargetMarket Perform ➝ Market Perform$170.00 ➝ $160.00High
i
Rating by David Larsen at SVB Leerink LLC
4/11/2018Bank of AmericaLower Price TargetBuy ➝ Buy$179.00 ➝ $172.00Low
i
Rating by Michael Cherny at Bank of America Co.
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$165.00Medium
i
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$179.00Low
i
2/2/2018Credit Suisse GroupReiterated RatingSell$130.00High
i
2/2/2018MizuhoLower Price TargetNeutral ➝ Neutral$186.00 ➝ $179.00High
i
Rating by Ann Hynes at Mizuho
1/24/2018MizuhoSet Price TargetHold$186.00Low
i
Rating by Ann Hynes at Mizuho
1/24/2018Jefferies Financial GroupUpgradeHold ➝ Buy$205.00High
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
1/23/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$173.00 ➝ $180.00Medium
i
Rating by Kevin Caliendo at Needham & Company LLC
1/17/2018Robert W. BairdReiterated RatingBuy$200.00Low
i
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$179.00Low
i
12/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$175.00High
i
11/9/2017Credit Suisse GroupReiterated RatingUnderperform$155.00 ➝ $130.00N/A
i
11/1/2017Needham & Company LLCReiterated RatingBuy ➝ Buy$178.00 ➝ $173.00N/A
i
Rating by Kevin Caliendo at Needham & Company LLC
10/27/2017Royal Bank of CanadaReiterated RatingHold$170.00N/A
i
10/24/2017MizuhoSet Price TargetHold$168.00N/A
i
Rating by Ann Hynes at Mizuho
10/24/2017Needham & Company LLCSet Price TargetBuy$179.00 ➝ $178.00N/A
i
Rating by Kevin Caliendo at Needham & Company LLC
10/18/2017Jefferies Financial GroupSet Price TargetHold$165.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/16/2017Needham & Company LLCSet Price TargetBuy$179.00N/A
i
Rating by Kevin Caliendo at Needham & Company LLC
10/10/2017CowenUpgradeMarket Perform ➝ Outperform$176.00 ➝ $189.00N/A
i
9/19/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$168.00Low
i
9/19/2017Robert W. BairdUpgradeNeutral ➝ Outperform$175.00 ➝ $178.00Low
i
9/14/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$184.00 ➝ $172.00High
i
9/8/2017Needham & Company LLCUpgradeHold ➝ Buy$179.00Low
i
8/29/2017Jefferies Financial GroupSet Price TargetHold$165.00Low
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
7/27/2017Jefferies Financial GroupUpgradeHold ➝ Buy$153.00Low
i
6/29/2017SVB LeerinkBoost Price TargetMarket Perform$170.00Medium
i
Rating by David Larsen at SVB Leerink LLC
6/26/2017UBS GroupReiterated RatingNeutral$156.00 ➝ $166.00N/A
i
6/4/2017BarclaysSet Price TargetBuy$187.00Low
i
Rating by Eric Percher at Barclays PLC
5/30/2017MizuhoBoost Price TargetNeutral ➝ Neutral$147.00 ➝ $168.00Low
i
5/25/2017Morgan StanleyBoost Price TargetOverweight$165.00 ➝ $179.00Low
i
5/23/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$189.00Medium
i
5/19/2017SVB LeerinkSet Price TargetHold$140.00High
i
Rating by David Larsen at SVB Leerink LLC
5/19/2017UBS GroupBoost Price TargetNeutral ➝ Neutral$145.00 ➝ $156.00N/A
i
5/17/2017Jefferies Financial GroupInitiated CoverageHold ➝ Hold$153.00Medium
i
4/27/2017BarclaysReiterated RatingOverweight$174.00Low
i
4/21/2017SVB LeerinkReiterated RatingHold$140.00Low
i
Rating by David Larsen at SVB Leerink LLC
4/17/2017Evercore ISIReiterated RatingOutperform$166.00Low
i
4/4/2017Needham & Company LLCInitiated CoverageHoldLow
i
3/6/2017CitigroupBoost Price TargetBuy$169.00 ➝ $175.00N/A
i
3/3/2017Credit Suisse GroupReiterated RatingSellN/A
i
1/21/2017SVB LeerinkSet Price TargetHold$155.00N/A
i
Rating by David Larsen at SVB Leerink LLC
1/18/2017Avondale PartnersUpgradeMarket Perform ➝ Outperform$157.00 ➝ $193.00N/A
i
Rating by G. Bolan at Avondale Partners
1/5/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$171.00 ➝ $169.00N/A
i
1/3/2017MizuhoDowngradeBuy ➝ Neutral$147.00N/A
i
11/23/2016Credit Suisse GroupDowngradeNeutral ➝ Underperform$150.00 ➝ $131.00N/A
i
11/11/2016Standpoint ResearchDowngradeBuy ➝ HoldN/A
i
11/9/2016MizuhoUpgradeNeutral ➝ Buy$147.00N/A
i
Rating by Ann Hynes at Mizuho
10/28/2016Standpoint ResearchUpgradeHold ➝ Buy$156.00N/A
i
10/28/2016Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$196.00 ➝ $153.00N/A
i
10/28/2016SVB LeerinkDowngradeOutperform ➝ Market PerformN/A
i
Rating by D. Larsen at SVB Leerink LLC
10/28/2016Robert W. BairdDowngradeOutperform ➝ Neutral$200.00 ➝ $164.00N/A
i
Rating by Eric Coldwell at Robert W. Baird
10/5/2016UBS GroupInitiated CoverageNeutral$182.00N/A
i
9/26/2016MizuhoLower Price TargetNeutral$197.00 ➝ $183.00N/A
i
Rating by Ann Hynes at Mizuho
9/19/2016ArgusReiterated RatingHoldN/A
i
9/16/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$210.00 ➝ $189.00N/A
i
9/1/2016SVB LeerinkReiterated RatingOutperform$230.00N/A
i
8/11/2016MizuhoBoost Price TargetNeutral$174.00 ➝ $197.00N/A
i
Rating by Ann Hynes at Mizuho
8/9/2016JPMorgan Chase & Co.Boost Price TargetOverweight$210.00 ➝ $221.00N/A
i
Rating by Lisa Gill at JPMorgan Chase & Co.
7/28/2016Morgan StanleyBoost Price TargetOverweight$199.00 ➝ $211.00N/A
i
Rating by Ricky Goldwasser at Morgan Stanley
7/28/2016CitigroupBoost Price TargetBuy$215.00 ➝ $225.00N/A
i
7/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
7/6/2016Avondale PartnersReiterated RatingMarket Perform$172.00 ➝ $197.00N/A
i
6/30/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Lisa Gill at JPMorgan Chase & Co.
6/30/2016Bank of AmericaReiterated RatingHoldN/A
i
Rating by Steven Valiquette at Bank of America Co.
6/29/2016Robert W. BairdReiterated RatingBuy$220.00N/A
i
Rating by Eric Coldwell at Robert W. Baird
6/29/2016FBR & CoReiterated RatingBuy$210.00N/A
i
Rating by Steven Halper at FBR & Co
6/22/2016FBR & CoReiterated RatingBuyN/A
i
Rating by Steven Halper at FBR & Co
6/8/2016Bank of AmericaInitiated CoverageHoldN/A
i
Rating by Steven Valiquette at Bank of America Co.
6/7/2016Bank of AmericaReiterated RatingNeutral$190.00N/A
i
6/7/2016MizuhoReiterated RatingNeutral$164.00 ➝ $174.00N/A
i
Rating by Ann Hynes at Mizuho
6/4/2016FBR & CoReiterated RatingBuyN/A
i
Rating by Steven Halper at FBR & Co
6/1/2016Raymond JamesDowngradeStrong-Buy ➝ OutperformN/A
i
5/31/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Ricky Goldwasser at Morgan Stanley
5/16/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Robert Willoughby at Credit Suisse Group AG
5/5/2016SVB LeerinkReiterated RatingBuy$200.00N/A
i
5/5/2016Avondale PartnersDowngradeOutperform ➝ Market Perform$203.00 ➝ $172.00N/A
i
Rating by G. Bolan at Avondale Partners
4/26/2016Standpoint ResearchDowngradeBuy ➝ HoldN/A
i
4/18/2016Avondale PartnersInitiated CoverageOutperform$203.00N/A
i
4/15/2016The Goldman Sachs GroupReiterated RatingBuy$188.00N/A
i
4/12/2016UBS GroupReiterated RatingBuyN/A
i
3/17/2016FBR & CoReiterated RatingOutperformN/A
i
Rating by Steven Halper at FBR & Co
3/16/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
3/15/2016Credit Suisse GroupInitiated CoverageNeutral$175.00N/A
i
3/15/2016CowenDowngradeOutperform ➝ Market Perform$208.00 ➝ $173.00N/A
i
3/11/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
Rating by David Francis at Royal Bank of Canada
3/1/2016MizuhoDowngradeBuy ➝ Neutral$193.00 ➝ $164.00N/A
i
Rating by Ann Hynes at Mizuho
2/26/2016FBR & CoReiterated RatingBuyN/A
i
Rating by Steven Halper at FBR & Co
2/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/10/2016Standpoint ResearchUpgradeHold ➝ Buy$184.00N/A
i
1/29/2016SVB LeerinkLower Price TargetOutperform$250.00 ➝ $200.00N/A
i
1/27/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$200.00 ➝ $199.00N/A
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
1/15/2016BarclaysReiterated RatingOverweight$220.00 ➝ $211.00N/A
i
Rating by Eric Percher at Barclays PLC
1/15/2016MizuhoLower Price TargetBuy$210.00 ➝ $193.00N/A
i
Rating by Ann Hynes at Mizuho
1/14/2016FBR & CoReiterated RatingBuyN/A
i
Rating by Steven Halper at FBR & Co
1/12/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$234.00 ➝ $200.00N/A
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
1/12/2016FBR & CoLower Price TargetOutperform$240.00 ➝ $210.00N/A
i
1/12/2016UBS GroupReiterated RatingBuy$260.00 ➝ $235.00N/A
i
1/12/2016Robert W. BairdLower Price Target$239.00 ➝ $195.00N/A
i
1/12/2016The Goldman Sachs GroupLower Price Target$214.00 ➝ $191.00N/A
i
1/12/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/A
i
1/12/2016Royal Bank of CanadaLower Price TargetOutperform$220.00 ➝ $190.00N/A
i
1/6/2016Raymond JamesDowngradeStrong-Buy ➝ Outperform$225.00N/A
i
(Data available from 11/28/2015 forward)
McKesson logo
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Read More

Today's Range

Now: $180.00
$179.10
$181.77

50 Day Range

MA: $163.20
$143.79
$183.66

52 Week Range

Now: $180.00
$112.60
$187.67

Volume

469,433 shs

Average Volume

2,354,012 shs

Market Capitalization

$28.90 billion

P/E Ratio

13.70

Dividend Yield

0.94%

Beta

0.81